000			02046 a2200553 4500
005			20250514013414.0
264		0	_c20011204
008			200112s 0 0 eng d
022			_a1530-6860
024	7		_a10.1096/fj.01-0072com _2doi
040			_aNLM _beng _cNLM
100	1		_aIm, S H
245	0	0	_aSuppression of experimental myasthenia gravis, a B cell-mediated autoimmune disease, by blockade of IL-18. _h[electronic resource]
260			_bFASEB journal : official publication of the Federation of American Societies for Experimental Biology _cOct 2001
300			_a2140-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAbatacept
650	0	4	_aAnimals
650	0	4	_aAntibodies _xtherapeutic use
650	0	4	_aAntigens, CD
650	0	4	_aAntigens, Differentiation _xbiosynthesis
650	0	4	_aB-Lymphocytes _ximmunology
650	0	4	_aCD40 Ligand _xmetabolism
650	0	4	_aCTLA-4 Antigen
650	0	4	_aCells, Cultured
650	0	4	_aCytokines _xbiosynthesis
650	0	4	_aDisease Progression
650	0	4	_aFemale
650	0	4	_aHypersensitivity, Delayed _xtherapy
650	0	4	_aImmunoconjugates
650	0	4	_aImmunoglobulin G _xbiosynthesis
650	0	4	_aInterleukin-18 _xantagonists & inhibitors
650	0	4	_aKinetics
650	0	4	_aLymphocyte Activation
650	0	4	_aMyasthenia Gravis, Autoimmune, Experimental _ximmunology
650	0	4	_aRats
650	0	4	_aRats, Inbred Lew
650	0	4	_aReceptors, Nicotinic _ximmunology
650	0	4	_aT-Lymphocytes _ximmunology
650	0	4	_aTh1 Cells _ximmunology
650	0	4	_aTransforming Growth Factor beta _xbiosynthesis
700	1		_aBarchan, D
700	1		_aMaiti, P K
700	1		_aRaveh, L
700	1		_aSouroujon, M C
700	1		_aFuchs, S
773	0		_tFASEB journal : official publication of the Federation of American Societies for Experimental Biology _gvol. 15 _gno. 12 _gp. 2140-8
856	4	0	_uhttps://doi.org/10.1096/fj.01-0072com _zAvailable from publisher's website
999			_c11559668 _d11559668